NIDCR funds $102M in research over 2 years
The National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health, used $101.8 million in American Recovery and Reinvestment Act funds
The National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health, used $101.8 million in American Recovery and Reinvestment Act funds
Despite a growing body of research pointing to the role of sexually transmitted diseases in increasing rates of oral cancers, young adults who smoke, drink,
A key link between the human ephrin-B1 gene and cleft palate and other craniofacial anomalies associated with craniofrontonasal syndrome (CFNS) has been demonstrated by researchers
A biopsy-based approach can improve the diagnosis of burning mouth syndrome (BMS), according to a study in the Clinical Journal of Pain (July/August 2010, Vol.
More than 33 million people worldwide were living with HIV/AIDS at the end of 2008, according to the World Health Organization. Compared to nine countries
A new test for oral cancer that a dentist could perform by simply using a brush to collect cells from a patient’s mouth, then analyzing
The spread of cancer cells in the tongue may be reduced if a gene that regulates cancer cell migration can be controlled, according to a
Case Western Reserve University School of Dental Medicine researchers have discovered a biomarker, human beta defensin-3 (hBD-3), that may serve as an early warning sign
Osteonecrosis of the jaw (ONJ) could be caused by an interaction between nitrogen-containing bisphosphonates and compromised vitamin D function, according to a new animal study
Using an off-the-shelf digital camera, Rice University biomedical engineers and researchers from the University of Texas M. D. Anderson Cancer Center have created an inexpensive
The presence of human papillomavirus (HPV) in tumors is the most important predictor of survival for people diagnosed with oropharyngeal cancer, according to a new
A powerful carcinogen found in tobacco smoke — dibenzo[a,l]pyrene — can be used for oral cancer research in experimental animals, providing a new model for